Possible Involvement of Monoaminergic Neurotransmission in Antidepressant-like activity of Emblica officinalis Fruits in Mice

CNS Neuroscience and Therapeutics

Volumn 18, Issue 5, 2012, Pages 419-425

  Dhingra, Dinesh ^a   Joshi, Parul ^a   Gupta, Arun ^a   Chhillar, Ritu ^a  

^a GURU JAMBHESHWAR UNIVERSITY OF SCIENCE AND TECHNOLOGY   (India)

Author keywords

Depression; Emblica officinalis; Forced swim test; GABA; MAO; Tail suspension test

Indexed keywords

4 AMINOBUTYRIC ACID; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; ANTIDEPRESSANT AGENT; ASCORBIC ACID; BACLOFEN; EMBLICA OFFICINALIS EXTRACT; FENCLONINE; FLAVANOID; FLUOXETINE; IMIPRAMINE; PHENELZINE; POLYPHENOL DERIVATIVE; PRAZOSIN; SULPIRIDE;

ANIMAL EXPERIMENT; ANTIDEPRESSANT ACTIVITY; ANTIOXIDANT ACTIVITY; AQUEOUS SOLUTION; ARTICLE; ATTENUATION; CONTROLLED STUDY; DEPRESSION; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; EMBLICA OFFICINALIS; ENZYME ACTIVITY; EXPERIMENTAL TEST; FORCED SWIMMING TEST; FRUIT; IMMOBILIZATION; LOCOMOTION; LOW DRUG DOSE; MALE; MONOAMINERGIC SYSTEM; MOUSE; NEUROTRANSMISSION; NONHUMAN; TAIL SUSPENSION TEST; TREATMENT DURATION;

ANIMALS; ANTIDEPRESSIVE AGENTS; ASCORBIC ACID; BIOGENIC MONOAMINES; DEPRESSION; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FRUIT; GAMMA-AMINOBUTYRIC ACID; HINDLIMB SUSPENSION; MALE; MICE; MONOAMINE OXIDASE; MOTOR ACTIVITY; PHYLLANTHUS EMBLICA; PHYTOTHERAPY; PLANT PREPARATIONS; SWIMMING; TIME FACTORS;

EID: 84860278485     PISSN: 17555930     EISSN: 17555949     Source Type: Journal    
DOI: 10.1111/j.1755-5949.2011.00256.x     Document Type: Article

References (46)

1. Moussavi S, Chatterji S, Verdes E, Tandon A, Patel V, Ustun B. Depression, chronic diseases, and decrements in health: Results from the World Health Surveys. Lancet 2007;370:851-858.
2. Millan MJ. The role of monoamines in the actions of established and "novel" antidepressant agents: A critical review. Eur J Pharmacol 2004;500:371-384.
3. Wong M, Licinio J. Research and treatment approaches to depression. Nat Rev Neurosc 2001;2:343-351.
4. Rang HP, Dale MM, Ritter JM, Moore PK. Pharmacology, 5th ed. Kidlington, Oxford, UK: Churchill Livingstone : an imprint of Elsevier, 2003;535-549.
5. Esel E, Kose K, Turan MT, et al. Monoamine oxidase-B activity in alcohol withdrawal of smoker. Is there any relationship with aggressiveness. Alcohol Alcohol 2002;37:272-276.
6. Krishnan KRR. Monoamine oxidase inhibitors. In: Schatzberg AF, Nemeroff CB, editors. Textbook of Psychopharmacology, 2nd ed. Washington, DC : American Psychiatric Press, 1998;239-249.
7. Yu ZF, Kong LD, Chen Y. Antidepressant activity of aqueous extracts of Curcuma longa in mice. J Ethnopharmocol 2002;83:161-165.
8. Behnke K, Jensen GS, Graubaum HJ, Gruenwald J. Hypericum perforatum versus fluoxetine in the treatment of mild to moderate depression. Adv Ther 2002;19:43-53.
9. Thakur RS, Puri HS, Husain A. Major Medicinal Plants of India. Central Institute of Medicinal and Aromatic Plants, Lucknow, India, 1989.
10. Scartezzini P, Antognoni F, Raggi MA, Poli F, Sabbioni C. Vitamin C content and antioxidant activity of the fruit and of the Ayurvedic preparation of Emblica officinalis Gaertn. J Ethnopharmacol 2006;104:113-118.
11. Pemminati S, Nair V, Dorababu P, Gopalakrishna HN, Pai MRSM. Effect of aqueous fruit extract of Emblica officinalis on haloperidol induced catalepsy in albino mice. J Clin Diagnostic Res 2009;3:1657-1662.
12. Pemminati S, Gopalakrishna HN, Swati B, Shreyasi C, Pai MRSM, Nair V. Antianxiety effect of aqueous extract of fruits of Emblica officinalis on acute and chronic administration in rats. J Pharm Res 2010;3:219-223.
13. Vasudevan M, Parle M. Memory enhancing activity of Anwala churna (Emblica officinalis Gaertn.): An Ayurvedic preparation. Physiol Behav 2007;91:46-54.
14. Bhattacharya A, Ghosal S, Bhattacharya SK. Antioxidant activity of tannoid principles of Emblica officinalis (amla) in chronic stress induced changes in rat brain. Indian J Exp Biol 2000;38:877-880.
15. Golechha M, Bhatia J, Arya DS. Hydroalcoholic extract of Emblica officinalis Gaertn. affords protection against PTZ-induced seizures, oxidative stress and cognitive impairment in rats. Indian J Exp Biol 2010;48:474-478.
16. Jose KJ, Kuttan R. Hepatoprotective activity of Emblica officinalis and Chyavanprash. J Ethnopharmacol 2000;72:135-140.
17. Kim HJ, Yokozawa T, Kim HY, Tohda C, Rao TP, Juneja LR. Influence of amla (Emblica officinalis Gaertn.) on hypocholesterolemia and lipid peroxidation in cholesterol-fed rats. J Nutr Sci Vitaminol 2005;51:413-418.
18. Sairam K, Rao CV, Dora BM, Vijay KK, Agarwal VK, Goel RK. Antiulcerogenic effect of methanolic extract of Emblica officinalis: An experimental study. J Ethnopharmacol 2002;82:1-9.
19. Suryanarayan P, Saraswat M, Petrash JM, Reddy GB. Emblica officinalis and its enriched tannoids delay streptozotocin-induced diabetic cataract in rats. Mol Vis 2007;24:1291-1297.
20. Saeed S, Tariq P. Antimicrobial activities of Emblica officinalis and Coriandrum sativum against gram positive bacteria and Candida albicans. Pak J Bot 2007;39:913-917.
21. Muthuraman A, Sood S, Singla SK. The antiinflammatory potential of phenolic compounds from Emblica officinalis L. in rat. Inflammopharmacology 2010; [Epub ahead of print].
22. Jose JK, Kuttan Y, Kuttan R. Antitumor activity of Emblica officinalis. J Ethnopharmacol 2001;75:65-69.
23. Perianayagam JB, Sharma SK, Joseph A, Christina AJ. Evaluation of anti-pyretic and analgesic activity of Emblica officinalis Gaertn. J Ethnopharmacol 2004;95:83-85.
24. Qureshi SA, Asad W, Sultana V. The effect of Phyllanthus emblica Linn on type-II diabetes, triglycerides and liver specific enzymes. Pak J Nutr 2009;8:125-128.
25. Ghosal S, Triethi VK, Chauhan S. Active constituents of Emblica officinalis: Part 1.-The chemistry and antioxidative effects of two new hydrolysable tannins, Emblicanin A and B. Indian J Chem 1996;35B:941-948.
26. Bhattacharya A, Chatterjee A, Ghosal S, Bhattacharya SK. Antioxidant activity of active tannoid principles of Emblica officinalis (amla). Indian J Exp Biol 1999;37:676-680.
27. Ram S, Raja T. Studies on naturally occuring gibberellins in amla (Emblica officinalis) fruit. New Phytol 1978;81:513-519.
28. Rehman HU, Yasin KA, Choudhary MA, et al. Studies on the chemical constituents of Phyllanthus emblica. Nat Prod Res 2007;21:775-781.
29. Luo W, Zhao M, Yang B, Shen G, Rao G. Identification of bioactive compounds in Phyllanthus emblica L. fruit and their free radical scavenging activities. Food Chem 2009;114:499-504.
30. Li W, Li QJ, An SC. Preventive effect of estrogen on depression-like behavior induced by chronic restraint stress. Neurosci Bull 2010;26:140-146.
31. Rodrigues AS, da Silva GL, Mateussi AS, et al. Involvement of monoaminergic system in the antidepressant-like effect of the hydroalcoholic extract of Siphocampylus verticillatus. Life Sci 2002;70:1347-1358.
32. Binfaré RW, Rosa AO, Lobato KR, Santos AR, Rodrigues AL. Ascorbic acid administration produces an antidepressant-like effect: Evidence for the involvement of monoaminergic neurotransmission. Prog Neuropsychopharmacol Biol Psychiatry 2009;33:530-540.
33. Nakagawa Y, Ishima T, Ishibashi Y, Yoshii T, Takashima T. Involvement of GABA(B) receptor systems in action of antidepressants: Baclofen but not bicuculline attenuates the effects of antidepressants on the forced swim test in rats. Brain Res 1996;709:215-220.
34. Chinoy JJ, Singh YD, Gurumurthi K. Colorimetric determination of ascorbic acid turnover in plants. Indian J Plant Physiol 1976;22:122-130.
35. Porsolt RD, Bertin A, Jalfre M. Behavioral despair in mice: A primary screening test for antidepressants. Arch Int Pharmacodyn 1977;229:327-336.
36. Dhingra D, Sharma A. Antidepressant-like activity of Glycyrrhiza glabra L. in mouse models of immobility tests. Prog Neuropsychopharmacol Biol Psychiatry 2006;30:449-454.
37. Dhingra D, Sharma A. Antidepressant-like activity of n-hexane extract of nutmeg (Myristica fragrans) seeds in mice. J Med Food 2006;9:84-89.
38. Abel EL, Bilitzke PJ. A possible alarm substance in the forced swimming test. Physiol Behav 1990;48:233-239.
39. Steru L, Chermat R, Thierry B, Simon P. The tail suspension test: A new method for screening antidepressants in mice. Psychopharmacol (Berl) 1985;85:367-370.
40. Schurr A, Livne A. Differential inhibition of mitochondrial monoamine oxidase from brain by hashish components. Biochem Pharmacol 1976;25:1201-1203.
41. Pan Y, Kong L, Xia X, Zhang W, Xia W, Jiang F. Antidepressant-like effect of icariin and its possible mechanism in mice. Pharmacol Biochem Behav 2005;82:686-694.
42. Charles M, McEwen J. MAO activity in rabbit serum. In: Tabor H, Tabor CW, editors. Methods in Enzymology, XVIIB. New York and London : Academic Press, 1977;692-698.
43. Henry RJ, Cannon DC, Winkelman JW. Clinical chemistry, principles and techniques, 2nd ed. New York: Harper and Row, 1974.
44. Leonard BE. Fundamentals of Psychopharmacology, 3rd ed.Chichester, West Sussex: John Wiley & Sons, 2003;153-192.
45. Coyle JT, Puttfarcken P. Oxidative stress, glutamate and neurodegenerative disorders. Science 1993;262:689-695.
46. Bilici M, Efe H, Koroglu MA, Uydu HA, Bekaroglu M, Deger O. Antioxidative enzyme activities and lipid peroxidation in major depression: Alterations by antidepressant treatments. J Affect Disord 2001;64:43-51.